Sorry, you need to enable JavaScript to visit this website.
chris_boshoff_300x170_v1.jpg

Chris Boshoff, FRCP, FMedSci, Ph.D

Chief Oncology Officer, Executive Vice President

As Chief Oncology Officer and Executive Vice President, Chris Boshoff leads Pfizer’s Oncology research and development organization from drug discovery to approval (including Oncology research) and through early and late phase clinical development.

Prior to Pfizer, Chris was the founding Director of the University College London (UCL) Cancer Institute, London, U.K.  He earned a PhD from the Institute of Cancer Research in London and trained as a medical oncologist at the Royal Marsden and Royal Free Hospitals in London. He is a Fellow of the Royal College of Physicians and an elected Fellow of the U.K. Academy of Medical Sciences. Chris was appointed an Adjunct Professor at Yale University School of Medicine in 2014, and as a clinician scientist has published more than 150 articles, many highly cited, on cancer biology, tumor virology, and experimental cancer medicine.

At Pfizer, Chris and his team have delivered numerous cancer medicines from Phase 1 to global approvals. This includes overseeing many U.S. Food and Drug Administration breakthrough therapy and European Medicines Agency Priority Medicines (PRIME) designations and delivering various Companion Diagnostics for Pfizer’s precision medicines—all with the goal of delivering breakthrough medicines for patients with cancer.

Albert Bourla headshot
Dr. Albert Bourla

Chairman and Chief Executive Officer

headshot image of Pfizer's Andrew Baum
Andrew Baum, BM ChB

Chief Strategy and Innovation Officer, Executive Vice President

Alexandre_de_Germay_300X170.jpg
Alexandre de Germay

Chief International Commercial Officer, Executive Vice President

Dave Denton headshot
Dave Denton

Chief Financial Officer and Executive Vice President

Media Name: mikael_dolsten300x170_2019_v3.jpg
Mikael Dolsten, M.D., Ph.D.

Chief Scientific Officer, President, Pfizer Research & Development

Media Name: lidia_fonseca300x170.jpg
Lidia Fonseca

Chief Digital and Technology Officer, Executive Vice President

Media Name: rady-johnson300x170px.jpg
Rady Johnson

Chief Compliance, Quality and Risk Officer, Executive Vice President

d_lankler_headshot_300x170.jpg
Doug Lankler

General Counsel, Executive Vice President

Aamir Malik headshot
Aamir Malik

Chief U.S. Commercial Officer, Executive Vice President

Mike McDermott headshot
Mike McDermott

Chief Global Supply Officer, Executive Vice President

Payal Sahni Becher headshot
Payal Sahni Becher

Chief People Experience Officer, Executive Vice President

Sally Susman headshot
Sally Susman

Chief Corporate Affairs Officer, Executive Vice President

chris_boshoff_300x170_v1.jpg

Chris Boshoff, FRCP, FMedSci, Ph.D

Chief Oncology Officer, Executive Vice President

As Chief Oncology Officer and Executive Vice President, Chris Boshoff leads Pfizer’s Oncology research and development organization from drug discovery to approval (including Oncology research) and through early and late phase clinical development.

Prior to Pfizer, Chris was the founding Director of the University College London (UCL) Cancer Institute, London, U.K.  He earned a PhD from the Institute of Cancer Research in London and trained as a medical oncologist at the Royal Marsden and Royal Free Hospitals in London. He is a Fellow of the Royal College of Physicians and an elected Fellow of the U.K. Academy of Medical Sciences. Chris was appointed an Adjunct Professor at Yale University School of Medicine in 2014, and as a clinician scientist has published more than 150 articles, many highly cited, on cancer biology, tumor virology, and experimental cancer medicine.

At Pfizer, Chris and his team have delivered numerous cancer medicines from Phase 1 to global approvals. This includes overseeing many U.S. Food and Drug Administration breakthrough therapy and European Medicines Agency Priority Medicines (PRIME) designations and delivering various Companion Diagnostics for Pfizer’s precision medicines—all with the goal of delivering breakthrough medicines for patients with cancer.

Albert Bourla headshot
Dr. Albert Bourla

Chairman and Chief Executive Officer

headshot image of Pfizer's Andrew Baum
Andrew Baum, BM ChB

Chief Strategy and Innovation Officer, Executive Vice President

Alexandre_de_Germay_300X170.jpg
Alexandre de Germay

Chief International Commercial Officer, Executive Vice President

Dave Denton headshot
Dave Denton

Chief Financial Officer and Executive Vice President

Media Name: mikael_dolsten300x170_2019_v3.jpg
Mikael Dolsten, M.D., Ph.D.

Chief Scientific Officer, President, Pfizer Research & Development

Media Name: lidia_fonseca300x170.jpg
Lidia Fonseca

Chief Digital and Technology Officer, Executive Vice President

Media Name: rady-johnson300x170px.jpg
Rady Johnson

Chief Compliance, Quality and Risk Officer, Executive Vice President

d_lankler_headshot_300x170.jpg
Doug Lankler

General Counsel, Executive Vice President

Aamir Malik headshot
Aamir Malik

Chief U.S. Commercial Officer, Executive Vice President

Mike McDermott headshot
Mike McDermott

Chief Global Supply Officer, Executive Vice President

Payal Sahni Becher headshot
Payal Sahni Becher

Chief People Experience Officer, Executive Vice President

Sally Susman headshot
Sally Susman

Chief Corporate Affairs Officer, Executive Vice President